Top

Journal of Assisted Reproduction and Genetics

Published in:

01-12-2006 | ORIGINAL PAPER

Addressing the idiosyncratic needs of Orthodox Jewish couples requesting sex selection by preimplantation genetic diagnosis (PGD)

Authors: Richard V. Grazi, Joel B. Wolowelsky

Published in: Journal of Assisted Reproduction and Genetics | Issue 11-12/2006

Abstract

We report here on ethical considerations addressing the idiosyncratic needs of two Orthodox Jewish couples requesting sex selection through PGD. The patients’ considerations stem from generally healthy concerns, are not based on any gender biases and have little chance of having any major societal impact, given the idiosyncratic nature of the situation. Halakhah, the legal and ethical system of rabbinic Orthodox Judaism, generally opposes sex selection through PGD for nonmedical reasons, but would approve the procedure in these cases. Meeting these needs within the context of the doctor-patient relationship necessitates reconsidering to some extent the ASRM Ethics Committee guidelines.

Ethics Committee of the American Society of Reproductive Medicine. Sex selection and preimplantation genetic diagnosis. Fertil Steril 1999;72(4):595–7.CrossRef

Ethics Committee of the American Society of Reproductive Medicine. Preconception gender selection for nonmedical reasons. Fertil Steril 2002;75(5):861–4.

Robertson JA. Sex selection for gender variety by preimplantation genetic diagnosis. Fertil Steril 2002;78(3):463.PubMedCrossRef

Gleicher N, Karande V. Gender selection for nonmedical indications. Fertil Steril 2002;78(3):460–2.PubMedCrossRef

Grazi RV. Overcoming infertility. A guide for Jewish couples. New Milford, CT: The Toby Press; 2005.

Zilberstein Y. Selecting a fetus for implantation: Avoidance of birth defects and determining sex [Response to Richard V. Grazi, 1991]. Noam (8):47–8.

Avraham SA. Nishmat Avraham (4):180.

Barkam A. Orthodox and conservative rabbis object to allowing gender selection. Haaretz Hebrew Edition, 22 May 2005.

Pollack D, Bleich M, Reid CJ, Fadel MH. Classical religious perspectives of adoption law. Notre Dame Law Rev 2004;79(2):693–4.

10.

Shafran Y. E-mail to Joel B. Wolowelsky, 1 November 2005.

11.

Lichtenstein A. Responsum to Richard V. Grazi, 29 Sivan 5651 [11 June 1991].

12.

Traubmann T, Shadmi H. Couple allowed to choose baby’s gender to avoid halakhic dilemma. Haaretz English ed. 18 October 2002.

13.

Serour GI, Dickson BM. Assisted reproduction developments in the Islamic world. Int J Obstet Gynecol 2001;74:190.CrossRef

Title: Addressing the idiosyncratic needs of Orthodox Jewish couples requesting sex selection by preimplantation genetic diagnosis (PGD)
Authors: Richard V. Grazi
Joel B. Wolowelsky
Publication date: 01-12-2006
Publisher: Kluwer Academic Publishers-Plenum Publishers
Published in: Journal of Assisted Reproduction and Genetics / Issue 11-12/2006
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-006-9047-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Addressing the idiosyncratic needs of Orthodox Jewish couples requesting sex selection by preimplantation genetic diagnosis (PGD)

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11-12/2006

Reduction of perifollicular arterial blood flow resistance after hCG administration is a good indicator of the recovery of mature oocytes in ART treatment

IVF/ICSI in a woman with active acromegaly: Successful outcome following treatment with pegvisomant

Exposure of mouse cumulus cell nuclei to porcine ooplasmic extract eliminates TATA box protein binding to chromatin, but has no effect on DNA methylation

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?

A study of ovarian autotransplantation without vascular a pedicle in rats

Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole)